Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Plans underway to expand screening capacity by 50% for greater accessibility
Cancer cases in India estimated to reach 1.57 million in 2025
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Based on DESTINY-Breast06 Phase III trial results which showed Enhertu demonstrated superiority vs. chemotherapy with a median progression-free survival of more than one year
Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform
The scheme is fully digitized and covers approximately 45% of India's population
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Subscribe To Our Newsletter & Stay Updated
